scorecardresearch
Sunday, September 7, 2025
TopicHydroxychloroquine

Topic: hydroxychloroquine

India sold over 22 crore HCQ tablets in last 3 months against 24 crore in all of 2019

The Rs 3-tablet, which earlier emerged as a front-runner for Covid treatment, also recorded a massive jump of 700 per cent in exports between March & May.  

Trump’s dash to Patanjali for Covid-19 ‘cure’, and Bollywood’s deadly nepotism

The best cartoons of the day, chosen by the editors at ThePrint.

US FDA revokes authorisation given for emergency use of HCQ to treat Covid

Chloroquine and hydroxychloroquine ‘are unlikely to be effective in treating Covid-19’, the US Food and Drug Administration said.

Health ministry revises stance on HCQ for Covid treatment, allows remdesivir for emergency use

In a new set of protocols, the ministry backtracked from its earlier stance and recommended HCQ in the early course of the disease but not in severe cases.

Why the HCQ-Trump-Lancet saga shouldn’t erode public trust in science

Science in the long haul is self-correcting, it never finds absolute truth, and it sometimes trips, but it can right itself and move on.

The Lancet, world’s most credible medical journal whose trust has been hit by HCQ scandal

‘The Lancet’ retracted a key study that linked anti-malarial drug HCQ to increased risk of death and irregularity in heart rhythms in coronavirus patients.

‘Star’ cardiologist Mehra & data doctor Desai — story of Indian experts behind HCQ scandal

Mandeep R. Mehra, who graduated from a medical college in Maharashtra, is now a professor at Harvard, while Sapan S. Desai founded the data analytics firm Surgisphere.

The HCQ study mess: How 3 Indian researchers put reputation of Lancet, NEJM at stake

In episode 489 of #CutTheClutter, Shekhar Gupta discusses the controversial studies that were retracted after scientists around the world raised questions on its data accuracy.

HCQ doesn’t reduce risk of death among hospitalised Covid patients, says Oxford study

About 26% of patients in the trial getting the drug died, compared with about 24% receiving standard care, according to the University of Oxford.

Surgisphere, the Indian-American founded tiny data firm at the centre of HCQ-Lancet storm

Sapan Desai, a 41-year-old surgeon, is the founder of the analytics company that prompted the retraction of two scientific articles, including one that spurred WHO to pause its drug trial.

On Camera

The Bengal Files has made sure Kolkata dusts history books to find out real Gopal Mukherjee

Whether it is due to the alleged unofficial ban on The Bengal Files or allegations by Gopal Mukherjee’s family against Agnihotri, everyone in the state wants to know more about Mukherjee.

Punjab’s paddy farmers are staring at big losses. Why flood impact may spill out of India’s rice bowl

As devastated farmers begin to come to terms with the fallout, 4 lakh hectares of land under paddy cultivation across state is flooded. Punjab is among the biggest contributors to PDS.

Army chief weighs in on theaterisation, says it is inevitable and need of the hour

New Delhi: Army chief General Upendra Dwivedi has strongly backed the idea of theaterisation, saying it is inevitable and the need of the hour. Speaking...

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?